Goetz M, Eichenlaub S, Pape G R, Hoffmann R M
Klinikum Grosshadern, Second Medical Department, University of Munich, Germany.
Transplantation. 2001 Jan 27;71(2):334-7. doi: 10.1097/00007890-200101270-00029.
Microsporidia are common pathogens among patients infected with human immunodeficiency virus. They account for a substantial proportion of chronic diarrhea and malabsorption in acquired immune deficiency syndrome, but their appearance after solid organ transplantation has only rarely been reported. Methods. We report what we believe is the first case of documented Enterocytozoon bieneusi infection in a liver transplant recipient. Results. Our patient presented with chronic diarrhea and colicky abdominal pain. Although symptoms were severe, only mild microscopical mucosal changes were found in the intestinal tract. A modified trichrome stain of stool specimens revealed microsporidial spores, and species differentiation by restriction fragment length polymorphism polymerase chain reaction identified Enterocytozoon bieneusi. Albendazole therapy brought symptomatic relief but no microbiological clearance.
Enterocytozoon bieneusi may cause chronic diarrhea not only in immunosuppression as a result of human immunodeficiency virus infection but also among patients with therapeutic immunosuppression after organ transplantation. Therefore, microsporidial infection should be considered in immunosuppressed patients with otherwise unexplained diarrhea.
微孢子虫是人类免疫缺陷病毒感染患者中的常见病原体。它们在获得性免疫缺陷综合征的慢性腹泻和吸收不良中占很大比例,但实体器官移植后其出现情况仅有极少报道。方法。我们报告了我们认为首例有记录的肝移植受者感染比氏肠胞微孢子虫的病例。结果。我们的患者表现为慢性腹泻和绞痛性腹痛。尽管症状严重,但肠道仅发现轻度显微镜下黏膜改变。粪便标本改良三色染色显示微孢子虫孢子,通过限制性片段长度多态性聚合酶链反应进行种属鉴别确定为比氏肠胞微孢子虫。阿苯达唑治疗使症状缓解,但未实现微生物学清除。
比氏肠胞微孢子虫不仅可在人类免疫缺陷病毒感染导致的免疫抑制中引起慢性腹泻,也可在器官移植后接受治疗性免疫抑制的患者中引起慢性腹泻。因此,对于有不明原因腹泻的免疫抑制患者应考虑微孢子虫感染。